Literature DB >> 22641002

Thyroid function: optimizing molecular testing in thyroid nodule cytology.

Furio Pacini1.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22641002     DOI： 10.1038/nrendo.2012.85

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  9 in total

1.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

2.  Clinical implication of highly sensitive detection of the BRAF V600E mutation in fine-needle aspirations of thyroid nodules: a comparative analysis of three molecular assays in 4585 consecutive cases in a BRAF V600E mutation-prevalent area.

Authors:  Seung-Tae Lee; Sun Wook Kim; Chang-Seok Ki; Ja-Hyun Jang; Jung Hee Shin; Young Lyun Oh; Jong-Won Kim; Jae Hoon Chung
Journal:  J Clin Endocrinol Metab       Date:  2012-04-12       Impact factor: 5.958

Review 3.  BRAF mutation in thyroid cancer.

Authors:  M Xing
Journal:  Endocr Relat Cancer       Date:  2005-06       Impact factor: 5.678

4.  BRAF V600E mutation does not predict recurrence after long-term follow-up in TNM stage I or II papillary thyroid carcinoma patients.

Authors:  Hanna Pelttari; Camilla Schalin-Jäntti; Johanna Arola; Eliisa Löyttyniemi; Sakari Knuutila; Matti J Välimäki
Journal:  APMIS       Date:  2011-11-25       Impact factor: 3.205

5.  Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology.

Authors:  Silvia Cantara; Marco Capezzone; Stefania Marchisotta; Serena Capuano; Giulia Busonero; Paolo Toti; Andrea Di Santo; Giuseppe Caruso; Anton Ferdinando Carli; Lucia Brilli; Annalisa Montanaro; Furio Pacini
Journal:  J Clin Endocrinol Metab       Date:  2010-02-03       Impact factor: 5.958

6.  Correlation between the BRAF V600E mutation and tumor invasiveness in papillary thyroid carcinomas smaller than 20 millimeters: analysis of 1060 cases.

Authors:  Fulvio Basolo; Liborio Torregrossa; Riccardo Giannini; Mario Miccoli; Cristiana Lupi; Elisa Sensi; Piero Berti; Rossella Elisei; Paolo Vitti; Angelo Baggiani; Paolo Miccoli
Journal:  J Clin Endocrinol Metab       Date:  2010-07-14       Impact factor: 5.958

7.  Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules.

Authors:  Yuri E Nikiforov; David L Steward; Toni M Robinson-Smith; Bryan R Haugen; Joshua P Klopper; Zhaowen Zhu; James A Fagin; Mercedes Falciglia; Katherine Weber; Marina N Nikiforova
Journal:  J Clin Endocrinol Metab       Date:  2009-03-24       Impact factor: 5.958

8.  BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer.

Authors:  Mingzhao Xing; Douglas Clark; Haixia Guan; Meiju Ji; Alan Dackiw; Kathryn A Carson; Matthew Kim; Anthony Tufaro; Paul Ladenson; Martha Zeiger; Ralph Tufano
Journal:  J Clin Oncol       Date:  2009-05-04       Impact factor: 44.544

9.  Cost impact of molecular testing for indeterminate thyroid nodule fine-needle aspiration biopsies.

Authors:  Linwah Yip; Coreen Farris; Adam S Kabaker; Steven P Hodak; Marina N Nikiforova; Kelly L McCoy; Michael T Stang; Kenneth J Smith; Yuri E Nikiforov; Sally E Carty
Journal:  J Clin Endocrinol Metab       Date:  2012-03-14       Impact factor: 5.958
  9 in total
  1 in total

1.  The analysis of differential diagnosis of benign and malignant thyroid nodules based on ultrasound reports.

Authors:  Shumei Miao; Mang Jing; Rongrong Sheng; Dai Cui; Shan Lu; Xin Zhang; Shenqi Jing; Xiaoliang Zhang; Tao Shan; Hongwei Shan; Tingyu Xu; Bing Wang; Zhongmin Wang; Yun Liu
Journal:  Gland Surg       Date:  2020-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.